Free Trial

Atb Cap Markets Has Bullish Estimate for Jushi Q3 Earnings

Jushi logo with Medical background

Key Points

  • Atb Cap Markets has revised its Q3 2025 earnings per share estimate for Jushi Holdings to ($0.05), an improvement from the previous estimate of ($0.06).
  • The company reported revenues of $65.05 million in its last quarterly earnings, inching above the consensus estimate of $64.67 million.
  • Jushi has a 52-week stock range between $0.22 and $0.69, with its current share price at $0.63.
  • Five stocks we like better than Jushi.

Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Equities research analysts at Atb Cap Markets increased their Q3 2025 EPS estimates for shares of Jushi in a report released on Tuesday, August 5th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings of ($0.05) per share for the quarter, up from their previous estimate of ($0.06). The consensus estimate for Jushi's current full-year earnings is ($0.23) per share. Atb Cap Markets also issued estimates for Jushi's Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.26) EPS and FY2026 earnings at ($0.19) EPS.

Jushi (OTCMKTS:JUSHF - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.06) EPS for the quarter, hitting the consensus estimate of ($0.06). The business had revenue of $65.05 million during the quarter, compared to analyst estimates of $64.67 million.

Jushi Trading Down 6.4%

Shares of JUSHF stock traded down $0.05 on Friday, reaching $0.75. 848,522 shares of the stock were exchanged, compared to its average volume of 227,272. The business's 50 day moving average price is $0.41 and its 200 day moving average price is $0.35. The company has a market capitalization of $147.32 million, a price-to-earnings ratio of -2.58 and a beta of -0.98. Jushi has a twelve month low of $0.22 and a twelve month high of $0.98.

About Jushi

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

See Also

Earnings History and Estimates for Jushi (OTCMKTS:JUSHF)

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines